BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 12823673)

  • 21. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood.
    Bux J; Becker F; Seeger W; Kilpatrick D; Chapman J; Waters A
    Br J Haematol; 1996 Jun; 93(3):707-13. PubMed ID: 8652399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfusion-related acute lung injury reports in the Netherlands: an observational study.
    van Stein D; Beckers EA; Sintnicolaas K; Porcelijn L; Danovic F; Wollersheim JA; Brand A; van Rhenen DJ
    Transfusion; 2010 Jan; 50(1):213-20. PubMed ID: 19694998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
    Curtis BR; McFarland JG
    Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfusion-related acute lung injury: current concepts for the clinician.
    Triulzi DJ
    Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
    Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
    Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Underdiagnosing of antibody-mediated transfusion-related acute lung injury: evaluation of cellular-based versus bead-based techniques.
    van Stein D; Beckers EA; Peters AL; Porcelijn L; Middelburg RA; Lardy NM; van Rhenen DJ; Vlaar AP
    Vox Sang; 2016 Jul; 111(1):71-8. PubMed ID: 26991993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities.
    Davoren A; Curtis BR; Shulman IA; Mohrbacher AF; Bux J; Kwiatkowska BJ; McFarland JG; Aster RH
    Transfusion; 2003 May; 43(5):641-5. PubMed ID: 12702187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody-mediated transfusion-related acute lung injury; from discovery to prevention.
    Peters AL; Van Stein D; Vlaar AP
    Br J Haematol; 2015 Sep; 170(5):597-614. PubMed ID: 25921271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefit of transfusion-related acute lung injury risk-minimization measures--German haemovigilance data (2006-2010).
    Funk MB; Guenay S; Lohmann A; Henseler O; Heiden M; Hanschmann KM; Keller-Stanislawski B
    Vox Sang; 2012 May; 102(4):317-23. PubMed ID: 21967322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human neutrophil antibodies in a blood donor population: a lookback study.
    Gottschall J; Triulzi D; Kakaiya R; Carrick D; Roback JD; Carey P; Kleinman S;
    Vox Sang; 2013 Feb; 104(2):166-70. PubMed ID: 22998453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are we missing reverse TRALI? - A real world experience from a tertiary care oncology centre in India.
    Basu D; Basu S; Datta SS
    Transfus Apher Sci; 2022 Dec; 61(6):103466. PubMed ID: 35654712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRALI risk reduction: donor and component management strategies.
    Eder AF; Benjamin RJ
    J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are we underestimating reverse TRALI?
    De Clippel D; Emonds MP; Compernolle V
    Transfusion; 2019 Sep; 59(9):2788-2793. PubMed ID: 31241780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA class II antibodies in transfusion-related acute lung injury.
    Kopko PM; Popovsky MA; MacKenzie MR; Paglieroni TG; Muto KN; Holland PV
    Transfusion; 2001 Oct; 41(10):1244-8. PubMed ID: 11606823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ninety-six suspected transfusion related acute lung injury cases: investigation findings and clinical outcome.
    Win N; Massey E; Lucas G; Sage D; Brown C; Green A; Contreras M; Navarrete C
    Hematology; 2007 Oct; 12(5):461-9. PubMed ID: 17852461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfusion-related alloimmune neutropenia with no pulmonary complications: one donor-five cases.
    Hauck-Dlimi B; Ruppel R; Zimmermann R; Strobel J; Reil A; Eckstein R; Zingsem J
    Transfusion; 2016 Jan; 56(1):84-90. PubMed ID: 26388439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion-related acute lung injury resulting from designated blood transfusion between mother and child: a report of two cases.
    Yang X; Ahmed S; Chandrasekaran V
    Am J Clin Pathol; 2004 Apr; 121(4):590-2. PubMed ID: 15080312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfusion-related acute lung injury associated with interdonor incompatibility for the neutrophil-specific antigen HNA-1a.
    Lucas G; Rogers S; Evans R; Hambley H; Win N
    Vox Sang; 2000; 79(2):112-5. PubMed ID: 11054050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How much residual plasma may cause TRALI?
    Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
    Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis.
    Müller MC; van Stein D; Binnekade JM; van Rhenen DJ; Vlaar AP
    Transfusion; 2015 Jan; 55(1):164-75. PubMed ID: 25135630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.